Holen Sie sich die Stockscreener-App
0.365
2.12%
-0.0079
Handel nachbörslich:
.38
0.015
+4.11%
Schlusskurs vom Vortag:
$0.3729
Offen:
$0.3735
24-Stunden-Volumen:
4.79M
Relative Volume:
3.44
Marktkapitalisierung:
$21.62M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-41.95M
KGV:
-0.4398
EPS:
-0.83
Netto-Cashflow:
$-38.34M
1W Leistung:
-3.62%
1M Leistung:
-4.20%
6M Leistung:
-45.52%
1J Leistung:
-86.53%
1-Tages-Spanne:
$0.3525
$0.3794
1-Wochen-Bereich:
$0.3525
$0.3803
52-Wochen-Spanne:
$0.221
$3.09
Elevation Oncology Inc Stock (ELEV) Company Profile
Firmenname
Elevation Oncology Inc
Sektor
Branche
Telefon
(716) 371-1125
Adresse
101 FEDERAL STREET, BOSTON
Vergleichen Sie ELEV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELEV
Elevation Oncology Inc
|
0.365 | 22.44M | 0 | -41.95M | -38.34M | -0.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Elevation Oncology Inc Stock (ELEV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-24 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2025-03-21 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-21 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-03-21 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-01-03 | Eingeleitet | William Blair | Outperform |
| 2024-05-31 | Eingeleitet | Piper Sandler | Overweight |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2024-03-01 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-05-30 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2021-12-23 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Elevation Oncology Inc Aktie (ELEV) Neueste Nachrichten
Elevation Oncology, Inc.(NasdaqCM: ELEV) dropped from S&P TMI Index - MarketScreener
Elevation Oncology Inc. Stock Analysis and ForecastDouble or triple returns - Autocar Professional
What drives Elevation Oncology Inc. stock priceAccelerated investment success - jammulinksnews.com
What analysts say about Elevation Oncology Inc. stockFree Market Dynamics Reports - jammulinksnews.com
Is Elevation Oncology Inc. a good long term investmentFree Expert Stock Watchlist - jammulinksnews.com
what makes elevation oncology inc. stock price move sharplySmart Trading With Safety Margin - Newser
What makes Elevation Oncology Inc. stock price move sharplyIntraday Trade Ideas - beatles.ru
Why Elevation Oncology Inc. stock attracts strong analyst attentionMomentum Buy Alert - beatles.ru
How Elevation Oncology Inc. stock performs during market volatilityMulti Bagger Alerts - Newser
Elevation Oncology Terminates EO-3021 Study Amid Implications for Future Research and Development Strategies - AInvest
EO-3021 Study Termination: Implications for Elevation Oncology and Partners - TipRanks
Elevation Oncology Terminates License Agreement with CSPC - TipRanks
Elevation Oncology ends license agreement with CSPC Megalith Biopharmaceutical - Investing.com
Elevation Oncology, Inc. (NASDAQ:ELEV) Receives $3.39 Average PT from Brokerages - Defense World
Analyzing Ratios: Elevation Oncology Inc (ELEV)’s Financial Story Unveiled - DWinneX
Elevation Oncology, Inc. (NASDAQ:ELEV) Sees Large Decline in Short Interest - Defense World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLS, ELEV, MTWO, CRKN on Behalf of Shareholders - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTCCRKN), Elevation Oncology, Inc. (NasdaqELEV), Sitio Royalties Corp. (NYSESTR), Vigil Neuroscience, Inc. (NasdaqV - TradingView
Research Analysts Set Expectations for ELEV FY2025 Earnings - Defense World
Q2 Earnings Estimate for ELEV Issued By Leerink Partnrs - Defense World
Equities Analysts Issue Forecasts for ELEV Q3 Earnings - Defense World
Wedbush Forecasts Reduced Earnings for Elevation Oncology - Defense World
Elevation Oncology (NASDAQ:ELEV) Cut to “Hold” at TD Cowen - Defense World
HC Wainwright Downgrades Elevation Oncology (NASDAQ:ELEV) to Neutral - Defense World
Elevation Oncology (NASDAQ:ELEV) Stock Rating Lowered by HC Wainwright - Defense World
Elevation Oncology (NASDAQ:ELEV) Downgraded by HC Wainwright to Neutral - Defense World
Elevation Oncology (NASDAQ:ELEV) Receives Market Perform Rating from JMP Securities - Defense World
Elevation Oncology (NASDAQ:ELEV) Lowered to Hold Rating by William Blair - Defense World
Elevation Oncology’s (ELEV) Neutral Rating Reaffirmed at HC Wainwright - Defense World
ELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevation Oncology, Inc.ELEV - Business Wire
Elevation Oncology (ELEV) Receives Analyst Rating Update | ELEV Stock News - GuruFocus
This McDonald's Analyst Turns Bearish; Here Are Top 4 Downgrades For Tuesday - Benzinga
Elevation Oncology (ELEV) Receives Downgrade from HC Wainwright & Co. | ELEV Stock News - GuruFocus
TD Cowen Downgrades Elevation Oncology to Hold From Buy - MarketScreener
HC Wainwright Downgrades Elevation Oncology to Neutral From Buy - marketscreener.com
Elevation Oncology (ELEV) Downgraded by H.C. Wainwright Amid Mer - GuruFocus
Elevation Oncology agrees to be acquired by Concentra - The Pharma Letter
Jane Street Group LLC Acquires 41,215 Shares of Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World
Millennium Management LLC Boosts Stock Holdings in Elevation Oncology, Inc. (NASDAQ:ELEV) - Defense World
Finanzdaten der Elevation Oncology Inc-Aktie (ELEV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):